Riskpilot← Back to searchSign inGet full accessHälsingeläkarna AB
ABActiveOrg 5566426531Backvägen 3General medical practice activities · NACE 8621Est. 200327 employees
Revenue 2025
SEK 30,4M
+3% vs 2024
EBITDA margin
4.5%
-25% vs 2024
Equity ratio
39.2%
Financial strength
Net profit 2025
SEK 1,1M
-25% vs 2024
| Revenue | SEK 30,4M | +3% |
| EBITDA | SEK 1,4M | -25% |
| Net profit | SEK 1,1M | -25% |
| Total assets | SEK 6,6M | -4% |
| Equity | SEK 2,6M | +14% |
| Employees | 27 | — |
Legal name
Hälsingeläkarna AB
Org number
5566426531
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
3 april 2003
Share capital
SEK 100 000
Employees
27 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall sälja läkar- och sjukgymnasttjänster inom sjukvårdsområdet, innefattande konsultverksamhet, bemanning, rehabilitering, friskvård, förebyggande hälsovård och utbildning, bedriva mottagningsverksamhet i egen regi och via avtal med uppdragsgivare, försäljning av rehabiliterings-, tränings- och ergonomisk utrustning, äga och förvalta fast egendom, bedriva handel med värdepapper, ävensom idka därmed förenlig verksamhet.
Address
Backvägen 3
Email
info@halsingelakarna.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 28 287 | 29 538 | 30 065 | 29 574 | 30 439 |
| Staff expenses | — | — | — | −15 158 | −18 038 |
| EBITDA | 2 893 | 3 488 | 3 380 | 1 850 | 1 379 |
| Depreciation & amort. | −26 | −41 | −36 | −34 | −40 |
| EBIT | 2 867 | 3 447 | 3 344 | 1 816 | 1 339 |
| Net financials | −1 | −9 | −17 | 44 | 70 |
| Profit before tax | 2 848 | 3 448 | 3 326 | 1 871 | 1 408 |
| Tax | −614 | −721 | −692 | −397 | −299 |
| Net profit | 2 234 | 2 727 | 2 634 | 1 474 | 1 109 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 7 745 | 8 639 | 7 577 | 6 825 | 6 583 |
| Equity | 3 434 | 4 161 | 4 295 | 2 269 | 2 578 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 4 211 | 4 448 | 3 253 | 4 536 | 3 986 |
| Total debt | 4 211 | 4 448 | 3 253 | 4 536 | 3 986 |
EBITDA margin
4.5%
This company
15.8%
Market median
-72% vs market
20212025
Equity ratio
39.2%
This company
38.2%
Market median
+3% vs market
20212025
Return on equity
43.0%
This company
18.4%
Market median
+134% vs market
20212025
Net profit margin
3.6%
This company
8.1%
Market median
-56% vs market
20212025
Asset turnover
4.62×
This company
1.12×
Market median
+312% vs market
20212025
Debt / equity
1.55×
This company
0.62×
Market median
-150% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ES Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Board of Directors | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hälsingeläkarna AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Susanne Lundholm | Audit | 0 companies |
| Aina Birgitta Ellström | Deputy Board Member | 0 companies |
| Lena Margareta Månström Bergqvist | Board of Directors | 0 companies |
| Per Andréus Granström | Board of Directors | 0 companies |